110 related articles for article (PubMed ID: 18700620)
21. Inhibition of phenolic glycolipid-I synthesis in extracellular Mycobacterium leprae as an indicator of antimicrobial activity.
Harris EB; Franzblau SG; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):588-91. PubMed ID: 3065422
[TBL] [Abstract][Full Text] [Related]
22. Immunological profile of treated lepromatous leprosy patients.
Joshi B; Girdhar BK; Mohanty KK; Beuria MK; Girdhar A; Sengupta U
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):195-203. PubMed ID: 11875763
[TBL] [Abstract][Full Text] [Related]
23. PGL I expression in live bacteria allows activation of a CD206/PPARγ cross-talk that may contribute to successful Mycobacterium leprae colonization of peripheral nerves.
Díaz Acosta CC; Dias AA; Rosa TLSA; Batista-Silva LR; Rosa PS; Toledo-Pinto TG; Costa FDMR; Lara FA; Rodrigues LS; Mattos KA; Sarno EN; Bozza PT; Guilhot C; de Berrêdo-Pinho M; Pessolani MCV
PLoS Pathog; 2018 Jul; 14(7):e1007151. PubMed ID: 29979790
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of polymerase chain reaction-based detection of Mycobacterium leprae for the diagnosis of leprosy.
Bang PD; Suzuki K; Phuong le T; Chu TM; Ishii N; Khang TH
J Dermatol; 2009 May; 36(5):269-76. PubMed ID: 19382997
[TBL] [Abstract][Full Text] [Related]
25. Role of PGL-I antibody detection in the diagnosis of pure neural leprosy.
Jardim MR; Antunes SL; Simons B; Wildenbeest JG; Nery JA; Illarramendi X; Moraes MO; Martinez AN; Oskam L; Faber WR; Sarno EN; Sampaio EP; Bührer-Sékula S
Lepr Rev; 2005 Sep; 76(3):232-40. PubMed ID: 16248210
[TBL] [Abstract][Full Text] [Related]
26. Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes.
Tabouret G; Astarie-Dequeker C; Demangel C; Malaga W; Constant P; Ray A; Honoré N; Bello NF; Perez E; Daffé M; Guilhot C
PLoS Pathog; 2010 Oct; 6(10):e1001159. PubMed ID: 20975946
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of anti-PGL-1, anti-35 kDa and anti-lipoarabinomannan assays for serodiagnosis of leprosy.
Jayapal V; Selvibai G; Mahalakshmi K; Pushkala ; Regunath K; Subramanian S
Indian J Lepr; 2001; 73(3):229-37. PubMed ID: 11840595
[TBL] [Abstract][Full Text] [Related]
28. Phenolic glycolipid-1 of Mycobacterium leprae is involved in human Schwann cell line ST8814 neurotoxic phenotype.
Girardi KDCV; Mietto BS; Dos Anjos Lima K; Atella GC; da Silva DS; Pereira AMR; Rosa PS; Lara FA
J Neurochem; 2023 Jan; 164(2):158-171. PubMed ID: 36349509
[TBL] [Abstract][Full Text] [Related]
29. Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes.
Schlesinger LS; Horwitz MA
J Exp Med; 1991 Nov; 174(5):1031-8. PubMed ID: 1940785
[TBL] [Abstract][Full Text] [Related]
30.
Chavarro-Portillo B; Soto CY; Guerrero MI
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240073
[TBL] [Abstract][Full Text] [Related]
31. Foot pad enlargement as a measure of induced immunity to Mycobacterium leprae.
Shepard CC; Minagawa F; Van Landingham R; Walker LL
Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):371-81. PubMed ID: 7009447
[TBL] [Abstract][Full Text] [Related]
32. The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophages.
Neill MA; Klebanoff SJ
J Exp Med; 1988 Jan; 167(1):30-42. PubMed ID: 2826638
[TBL] [Abstract][Full Text] [Related]
33. Immunogold labeling method for Mycobacterium leprae-specific phenolic glycolipid in glutaraldehyde-osmium-fixed and Araldite-embedded leprosy lesions.
Boddingius J; Dijkman HP
J Histochem Cytochem; 1989 Apr; 37(4):455-62. PubMed ID: 2926124
[TBL] [Abstract][Full Text] [Related]
34. Association between anti-pGL-I IgM and clinical and demographic parameters in leprosy.
Schuring RP; Moet FJ; Pahan D; Richardus JH; Oskam L
Lepr Rev; 2006 Dec; 77(4):343-55. PubMed ID: 17343221
[TBL] [Abstract][Full Text] [Related]
35. Assessment of subclinical leprosy infection through the measurement of PGL-1 antibody levels in residents of a former leprosy colony in Thailand.
Kampirapap K
Lepr Rev; 2008 Sep; 79(3):315-9. PubMed ID: 19009981
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor (TNF) production in leprosy patients.
Kaur I; Agnihotri N; Mehta M; Dogra S; Ganguly NK
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):249-50. PubMed ID: 11875771
[No Abstract] [Full Text] [Related]
37. Whole-blood culture is a valid low-cost method to measure monocytic cytokines - a comparison of cytokine production in cultures of human whole-blood, mononuclear cells and monocytes.
Damsgaard CT; Lauritzen L; Calder PC; Kjaer TM; Frøkiaer H
J Immunol Methods; 2009 Jan; 340(2):95-101. PubMed ID: 19000693
[TBL] [Abstract][Full Text] [Related]
38. PGL-III, a Rare Intermediate of
Ishizuka S; van Dijk JHM; Kawakita T; Miyamoto Y; Maeda Y; Goto M; Le Calvez G; Groot LM; Witte MD; Minnaard AJ; van der Marel GA; Ato M; Nagae M; Codée JDC; Yamasaki S
ACS Cent Sci; 2023 Jul; 9(7):1388-1399. PubMed ID: 37521780
[TBL] [Abstract][Full Text] [Related]
39. Design of a specific peptide against phenolic glycolipid-1 from Mycobacterium leprae and its implications in leprosy bacilli entry.
Arenas NE; Pieffet G; Rocha-Roa C; Guerrero MI
Mem Inst Oswaldo Cruz; 2022; 117():e220025. PubMed ID: 35857971
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of Mycobacterium leprae in macrophages.
Ramasesh N; Hastings RC; Krahenbuhl JL
Infect Immun; 1987 May; 55(5):1203-6. PubMed ID: 3552993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
